Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Manfred who wrote (1964)	5/2/1998 5:59:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

Been there, done that Thanks Manfred for responding to that message. I wonder what his motivation was for posting. I wonder if it could be that he is upset that he did not make the right investment decision. IF he actually had invested 6 months ago and had actually been following this board then he would have seen that this tactic has been tried numerous times by "those short people". For hopefully the last time: Bilirubin is M-O-N-I-T-E-R-E-D for every infant born. (monitor: to watch, keep track of, or check usually for a special purpose). Currently, if higher levels are suspected then a blood test is ordered to check the bilirubin level. Chromatics' device will eliminate the need for that invasive test. I wonder why "the doctor" is so busy posting on this board and not attending the conference this weekend. Really "up on things" I guess. From Message 3727878 : For many attendees, this is the only major medical research meeting they attend. Whether they are in a hospital, clinical, or private setting, they attend this meeting to learn the issues and technology that effect their practice and research. This meeting is the LARGEST PEDIATRIC RESEARCH meeting held. In addition to our own program, the following pediatric subspecialty clubs and symposia meet in conjunction with our annual meeting and exposition......

To: Manfred who wrote (1964)	5/2/1998 6:09:00 PM
From: STLMD	Read Replies (4) \| Respond to of 5736

Manfred, I read all the resources you quote and feel that this is an exaggeration of the NEWBORN market. This may be 15 mil bili tests in the US but that included all the tests done in liver panels including adults etc. I would ask you to clarify this with the company. Premature births are defined as less than 37 weeks gestation or less. Most of those are in the 34-37 week range and the incidence of jaundice in this population is somewhat higher . Our claims for infant bili tests in our IPA of more than 9000 supports the 10% claim that I made. It certainly does not come up to the numbers you or the company quotes. I again am not invested so you all should call the Doctors and the company and clarify their statements. Ask exactly how many bili tests are ordered on newborns and pediatric populations per year. Don't include adults etc. If you're claiming that over 150 il dollars are spent each year in the US on separate bili tests then your facts are wrong. Get info from supporting and independent sources, not those paid by the company to promote the product. As far as the forest from the trees remark, keep em coming, I believe we can have a meaningful discussion otherwise. You see, there are many of our ranks that are scientific, epidemiologically oriented and look at populations. So I would only reply if someone who is being paid to promote a product told you that a dog was a wolf, they would be in the right family but just ever so slightly exaggerating. Regards, Stephen PS: Give me the direct link to the WHO info. I haven't been able to find it myself regarding the numbers re bilirubin testing and I've certainly tried .